USDA approves parvo preventative for puppiesJune 27, 2025The conditional approval of the Canine Parvovirus Monoclonal Antibody (CPMA) for passive immunity allows veterinarians to protect exposed puppies from canine parvovirus.
SPONSORED CONTENTLife Gets Busy, Stay ON POINT With Cytopoint®Simplify your approach to allergic pruritus with Cytopoint. Help maintain control of allergic itch when schedules get hectic for both veterinarians and pet owners alike. + Learn more
5 Questions With…Hunter Finn, DVM, veterinarian-influencerSeptember 3, 2024Dr. Finn shares about the cases he sees in his practice, how he integrates the first USDA-conditionally approved Canine Parvovirus Monoclonal Antibody (CPMA) treatment to handle parvo cases, and his social media work.
Monoclonal antibody (mAb) product innovation aim of facility expansion in KansasAugust 23, 2024A $130-million investment through 2026 is expected to bolster production and development of monoclonal antibody-based therapy, including a potential product in canine dermatology.
